Rugby Labs' immediate-release diltiazem
Executive Summary
Rugby begins shipments Oct. 1 under an agreement with Cardizem maker Marion Merrell Dow ("The Pink Sheet" April 6, p. 3). Deal gives Rugby a jump on Mylan Labs, Copley Pharmaceuticals and Lederle; the three firms have received ANDA approvals for diltiazem, which become effective Nov. 5 following expiration of MMD's patent. The four dosage strengths of the Rugby diltiazem, which are being manufactured by MMD subsidiary Blue Ridge Labs, will be sold at an approximate 10% discount to the brandname product, according to Rugby.